FDA reported yesterday a program designed to leverage resources with other nations in an effort to hold flawed products at the border, but the agency's commissioner, Margaret Hamburg, MD, acknowledged on a conference call yesterday that the program might suffer from a lack of cash. (Medical Device Daily) Read More
